Taken together, our result indicates that HSD for a short period of 3 weeks in mice could significantly change the gut microbiota profile (phylum, family and genus level) known to develop the pathophysiological features of metabolic syndrome-related inflammation. The gene discussed is CHST3; the disease is metabolic syndrome.